Search results for "Coronavirus"
ACP, Annals of Internal Medicine host forum on the end of the COVID-19 Public Health Emergency
A full recording of “COVID-19 Is No Longer a Public Health Emergency: Implications for Patients and Clinicians” is available online.
https://immattersacp.org/weekly/archives/2023/05/23/6.htm
23 May 2023
Primary care's role in COVID-19 vaccination
Patients report that they trust their primary care practitioner the most, because a physician can address their problems in a real, personal way.
https://immattersacp.org/archives/2021/04/primary-cares-role-in-covid-19-vaccination.htm
1 Apr 2021
Register now for ACP and Annals of Internal Medicine's forum on the end of the COVID-19 Public Health Emergency
The virtual live event will be held on May 19 from 3:30 to 5 p.m. ET.
https://immattersacp.org/weekly/archives/2023/05/09/5.htm
9 May 2023
My ‘Zoom’ presidency
ACP's President reflects on how the pandemic has changed her ability to interact with members, patients, and even her own family.
https://immattersacp.org/archives/2020/09/my-zoom-presidency.htm
1 Sep 2020
PASC defined, analyzed by latest COVID-19 studies
Two recent studies focused on postacute sequelae of SARS-CoV-2 (PASC), while another assessed the effectiveness of nirmatrelvir-ritonavir and molnupiravir in reducing morbidity and mortality from COVID-19.
https://immattersacp.org/weekly/archives/2023/06/06/2.htm
6 Jun 2023
COVID-19 upends every aspect of visits
Several months into the COVID-19 pandemic, it's still uncertain to what degree it will reshape the practice of medicine and office management in the near and long terms.
https://immattersacp.org/archives/2020/07/covid-19-upends-every-aspect-of-visits.htm
1 Jul 2020
CBT improved severe fatigue after COVID-19, Dutch trial finds
After randomization, patients with severe fatigue three to 12 months after COVID-19 infection benefited from cognitive behavioral therapy (CBT) compared to usual care.
https://immattersacp.org/weekly/archives/2023/05/16/2.htm
16 May 2023
Studies look at effectiveness of bivalent booster, fluvoxamine plus inhaled budesonide for COVID-19
After four weeks, bivalent booster vaccines were 47.5% effective against hospitalization or death from COVID-19, a study in North Carolina found, while a Brazilian trial showed that fluvoxamine plus inhaled budesonide significantly reduced the risk of progression to severe disease among high-risk patients with symptomatic COVID-19.
https://immattersacp.org/weekly/archives/2023/04/18/2.htm
18 Apr 2023
The pain of 2020 and the hope for 2021
We have lost so much this past year, but loss also reminds us of our abundant blessings, so many we take for granted daily.
https://immattersacp.org/archives/2020/11/the-pain-of-2020-and-the-hope-for-2021.htm
1 Nov 2020
Payment parity for phone calls, COVID-19 research on remdesivir, other drugs
COVID-19-related disparities were also in the news this week.
https://immattersacp.org/weekly/archives/2020/05/04/1.htm
4 May 2020